Clinical Trials Directory

Pharmacokinetics of Ketamine in Infants and Children

Dosing of medications is based on the plasma level achieved with a given dose and how long the medicine remains in the body. This study is called pharmacokinetics-that is, what the body does to the medication. Ketamine is an intravenous medication used for anesthesia and sedation in children. However the pharmacokinetics of Ketamine has not been systematically studied. We propose to study the pharmacokinetics of ketamine in different age groups of children ranging from infants to teenagers.

Stanford is not currently accepting new patients for this trial. You may want to check clinicaltrials.gov to see if other locations are recruiting.

Investigator(s):

Intervention(s):

  • drug : ketamine hydrochloride

Phase: N/A

Eligibility

Ages Eligible For Study:

N/A - 17 Years

Inclusion Criteria

- Term infants (38 weeks gestation)and infants and children up to age 18 years. - Patients who require procedures that necessitate at least 8 hours in the hospital and those being admitted after procedure will be eligible to participate. - Patients who will receive ketamine as part of their standard anesthesia regimen.

External Links

Explore related trials

Contact information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Archana Verma
6507211713
Not Recruiting

Footer Links: